Literature DB >> 872488

Antibiotic-associated colitis.

R R Miller, H Jick.   

Abstract

Among 26,294 hospitalized patients monitored by the Boston Collaborative Drug Surveillance Program (BCDSP), 8,948 (34%) received at least one antibiotic, and none were diagnosed as having drug-induced colitis to in-hospital antibiotic exposure. Seven patients who had taken antibiotics as outpatients, however, were admitted with antibiotic-associated colitis. Six of these patients had taken lincomycin prior to the onset of symptoms; one had taken ampicillin. Six of the patients were hospitalized at a New Zealand hospital and one at a hospital in Canada. The five patients with lincomycin-associated colitis at the New Zealand hospital were admitted over an 11-month period. Severe colitis due to antibiotics has been a rare event in the BCDSP experience, especially in the United States.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 872488     DOI: 10.1002/cpt19772211

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  5 in total

1.  Pseudomembranous colitis associated with changes in an ileal conduit.

Authors:  J R Shortland; R C Spencer; J L Williams
Journal:  J Clin Pathol       Date:  1983-10       Impact factor: 3.411

2.  Antibiotic-associated colitis.

Authors:  A Stergachis; D R Perera; M M Schnell; H Jick
Journal:  West J Med       Date:  1984-02

3.  Oral bacteriotherapy in clinical practice. I. The use of different preparations in infants treated with antibiotics.

Authors:  G Zoppi; A Deganello; G Benoni; F Saccomani
Journal:  Eur J Pediatr       Date:  1982-09       Impact factor: 3.183

4.  Household pets as a potential reservoir for Clostridium difficile infection.

Authors:  S P Borriello; P Honour; T Turner; F Barclay
Journal:  J Clin Pathol       Date:  1983-01       Impact factor: 3.411

Review 5.  [Antibiotic-associated diarrhoea and enterocolitis (author's transl)].

Authors:  K Loeschke
Journal:  Klin Wochenschr       Date:  1980-04-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.